{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
<< Return to Beaumont CME
Beaumont Health
  • Sign In
  • Courses
  • On Demand
  • Grand Rounds Calendar
  • State Required CE
  • About Us
  • Planner Resources
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Use My Beaumont Login
Login with my CloudCMEâ„¢ account
Enter your email and password to login:



Login

New to CloudCME? Create an Account:

Create New Account
Forgot Your Password?

NOTE:  The CME/CE Portal is NOT linked to the Beaumont network.  Your log-in is the email address in your portal account and the password you set for this account.  

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##






Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numerical character
  • Must contain at least 1 special character


  • -- Select Degree --
  • BA
  • BS
  • BSN
  • CNM
  • CPhT
  • CRNA
  • DC
  • DDS
  • DMD
  • DNP
  • DO
  • DPM
  • DTR
  • LCSW
  • LPN
  • MA
  • MBA
  • MBChB
  • MD
  • MD, PhD
  • MHA
  • MPH
  • MS
  • MSN
  • MSW
  • ND
  • None
  • NP
  • OD
  • OT
  • Other
  • PA
  • PA-C
  • PharmD
  • PhD
  • PsyD
  • PT
  • PTA
  • RD
  • RDMS
  • RN
  • RPh
  • RT
  • RVT

Please enter your degree:





Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

VBS 2021: The Force Awakens Episode 1

  • Overview
  • Register
  • Faculty
  • Begin Activity


Date & Location
Sunday, August 1, 2021, 12:00 AM - Sunday, July 31, 2022, 11:59 PM

Overview

The primary goal of the Virtual Series is to bring retina surgeons together who are committed to sharing innovative strategies to foster best practices for the management of retinal pathologies.

Topics will include, but are not limited to, debates on secondary IOL approaches, macular degeneration treatments on the horizon, surgical approaches to trauma, diversity, equity and inclusion, surgical management of uveitis patients, debates on vitrectomy platforms, OCT interpretation, debates on approaches to macular hole repair, job contracts, and approaches to surgical complications.

VBS 2021: The Force Awakens, Episode 1  (Recording from April 14, 2021) 

Release Date: August 1, 2021  |  Expiration Date: July 31, 2022  |   Estimated Time to Complete: 90 minutes

Moderated by Aleksandra Rachitskaya, MD; Priya Sharma Vakharia, MD; Basil Williams, Jr., MD

  • Introduction - Charles Wykoff, MD, PhD
  • Do or do not do, there is no try: IOL Acrobatics Debates      
    • Scleral Haptic Fixation - Maria Berrocal, MD      
    • Gore-tex Sutered Lenses - Joseph Coney, MD      
    • Iris Sutured - Ninel Gregori, MD      
    • ACIOL - Katherine Talcott, MD      
    • Discussion + Voting
  • This is not the medical retina you were looking for: Surgical Approaches in Medical Retina and Discussion - Lejla Vajzovic, MD
  • Impressive, most impressive: Lightning Surgical Rounds - Matthew Cunningham, MD; Kristen Harris-Nwanyanwu, MD, MBA; Marianeli Rodriguez, MD
  • I find your lack of faith disturbing: Handling Trauma as a Retinal Surgeon and Discussion - Yewlin Chee, MD
  • Bringing Balance to the Force: Diversity, Equity, & Inclusion in Retina Panel - Moderated by Basil Williams, Jr., MD; Panelists - Jessica Randolph, MD; Reginald Sanders, MD
  • That's not how the Force works! Uveitis Surgery Pearls and Discussion - Lisa Faia, MD
  • Closing Remarks - Geeta Lalwani, MD

Target Audience
Specialties - Ophthalmology
Professions - Physician


Objectives
  1. Evaluate and treat patients with aphakia or dislocated lenses: including demonstration of different secondary lens approaches; explaining advantages and disadvantages of these various techniques; and comparing surgical outcomes between the secondary lens approaches.
  2. Describe emerging therapeutics for the treatment of neovascular age related macular degeneration that will potentially be available in the near future, including gene therapy and the port delivery system.
  3. Managing cases of intraocular trauma as a vitreoretinal surgeon, including demonstration of vitreoretinal surgical techniques in trauma and the application of advanced vitrectomy techniques.
  4. Discuss challenging vitreoretinal surgical cases and surgical techniques for successfully managing these cases.
  5. Discuss the status of diversity in ophthalmology, specifically within retina as a subspecialty, and formulate successful approaches to improving diversity, equity and inclusion in the retina space.
  6. Explain how to manage uveitis patients needing vitreoretinal surgery and the application of surgical techniques to successfully address complex vitreoretinal pathology in patients with uveitis.

Credits
AMA PRA Category 1 Creditsâ„¢ (1.50 hours), AMA PRA Non-Physician (Attendance) (1.50 hours)

Credit Information

In support of improving patient care, this activity has been planned and implemented by Beaumont Health, Medical Conference Planners, Intl. and Vit-Buckle Society.  Beaumont Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Medicine CME: Beaumont Health designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Additional Information

Commercial Support: This module is supported by educational grants from Alcon Vision, LLC, Bausch + Lomb and Regeneron Pharmaceuticals, Inc.

Unapproved Use: It is the policy of Beaumont Health to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this accredited CE activity may reference off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.

References:

www.vitbucklesociety.org/vit-buckle-academy

www.retinapodcast.com



Keywords: AMA



Mitigation of Relevant Financial Relationships: In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Beaumont Health implemented mechanisms to identify and mitigate relevant financial relationships with ineligible companies for all individuals in a position to control content of this activity.

Disclosures: Please click the faculty name to review the individual's financial relationships with ineligible companies.



Faculty Member Information
Role in activity
Name of Ineligible Company(s) / Nature of Relationship(s)
Maria Berrocal, MD
Berrocal & Associates
Faculty
Speakers Bureau-Alcon|Consultant/Advisor-Alcon|Speakers Bureau-Allergan|Consultant/Advisor-Alimera|Consultant/Advisor-Genentech, Inc.
Yewlin Chee, MD
University of Washington
Faculty
Nothing to disclose
Joseph Coney, MD
Retina Associates of Cleveland
Faculty
Research Grant-Aerpio|Consultant/Advisor-Alcon Laboratories|Consultant/Advisor-Alimera Sciences|Consultant/Advisor-Allergan|Research Grant-Apellis|Consultant/Advisor-Genentech, Inc.|Research Grant-Hoffman LaRoche|Consultant/Advisor-Novartis AG|Consultant/Advisor-Regeneron
Matthew Cunningham, MD
Florida retina institute
Faculty
Consultant/Advisor-Novartis AG|Consultant/Advisor-Alimera|Consultant/Advisor-Allergan
Lisa Faia, MD
Beaumont Eye Institute
Faculty
Nothing to disclose
Ninel Gregori, MD
University of Miami
Faculty
Consultant/Advisor-Astellas Regenerative Medicine|Research Grant-Biogen Idec
Geeta Lalwani, MD
Rocky Mountain Retina Assoc
Faculty
Nothing to disclose
Kristen H Nwanyanwu, MD, MBA, MHS
Yale University
Faculty
Nothing to disclose
Aleksandra Rachitskaya, MD
Cleveland Clinic
Faculty
Consultant/Advisor-Zeiss|Speakers Bureau-Regeneron|Research Grant-Genentech, Inc.|Consultant/Advisor-Alcon|Research Grant-Novartis AG
Jessica Randolph, MD
Virginia Commonwealth University
Faculty
Consultant/Advisor-Genentech, Inc.
Marianeli Rodriguez, MD, PhD
Vitreoretinal Associates PC
Faculty
Nothing to disclose
Reginald Sanders, MD
Retina Group of Washington
Faculty
Nothing to disclose
Katherine Talcott, MD
Cole Eye Institute
Faculty
Research Grant-Zeiss|Consultant/Advisor-Genentech, Inc.
Lejla Vajzovic, MD
Duke University
Faculty
Consultant/Advisor-DORC|Research Grant-Roche|Consultant/Advisor-Genentech, Inc.|Research Grant-Alcon|Consultant/Advisor-Alcon|Consultant/Advisor-Regenxbio|Research Grant-Regenxbio|Consultant/Advisor-Baush and Lomb|Research Grant-Heidelberg Engineering|Consultant/Advisor-Allergan|Research Grant-AGTC|Research Grant-Aldeyra|Consultant/Advisor-Gyroscope|Research Grant-Gyroscope|Consultant/Advisor-BVI|Consultant/Advisor-Novartis AG|Honorarium-Evolve Medical Education|Consultant/Advisor-Guidepoint
Priya Vakharia, MD
RVAF
Faculty
Nothing to disclose
Basil Williams, MD
University of Cincinnati
Faculty
Consultant/Advisor-Genentech, Inc.|Consultant/Advisor-Castle Biosciences
Charles Wykoff, MD, PhD
Retina Consultants of Texas
Faculty
Consultant/Advisor-Acucela, Adverum, Allergan, Apellis, Arctic Vision, Arrowhead, Bausch + Lomb, Bayer, Bionic Vision Technologies, Chengdu Kanghong Biotechnologies (KHB), Clearside Biomedical, DORC, EyePoint, Genentech, Gyroscope, IVERIC Bio, Kato DSRC, Kodiak Sciences, Merck NGM Biopharmaceuticals, Novartis, Novant Health,OccuRx, Ocular Therapeutix, ONL Therapeutics, Opthea, Oxurion (formerly Thrombogenics), Palatin, Pentavision, PolyPhotonix, RecensMedical, Regeneron, RegenXBio, Roche, SAI MedPartners, Takeda, Thea Open Innovation, Verana Health|Speakers Bureau-Regeneron|Stock Ownership-ONL Therapeutix, PolyPhotonix, RecensMedical, Visgenx|Research Grant-Adverum, Aerie Pharmaceuticals, Aldeyra, Alimera Sciences, Apellis, Bayer, Boehringer Ingelheim, Chengdu Kanghong Biotechnologies (KHB), Clearside Biomedical, Gemini Therapeutics, Genentech, Graybug Vision, Gyroscope, IONIS Pharmaceutical, IVERIC Bio, Kodiak Sciences, LMRI, Neurotech Pharmaceuticals, NGM Biopharmaceuticals, Novartis, Opthea, Outlook Therapeutics, Oxurion, Recens Medical, Regeneron, RegenXBio, Roche, SamChunDang Pharm., Santen, Senju, Taiwan Liposome Company, Xbrane BioPharma
Yoshihiro Yonekawa, MD
Wills Eye Hospital / Mid Atlantic Retina
Faculty
Consultant/Advisor-Alcon|Consultant/Advisor-Alimera|Consultant/Advisor-Allergan|Consultant/Advisor-Genentech

VBS 2021: The Force Awakens Episode 1
Register Launch Video Post-Test